FIELD: pharmacology.
SUBSTANCE: proposed: a pharmaceutical combination for treating melanoma comprising: (a) 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl) pyridin-4-yl] thiazol-2-yl}amide) (S)-pyrrolidine-1,2-dicarboxylic acid (compound A) or its pharmaceutically acceptable salt; and (b), at least, one Hsp90 inhibitor, representing ethylamide 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethyl-phenyl) isoxazole-3-carboxylic acid (AUY922) or its pharmaceutically acceptable salt; the use of the said combination for manufacturing drugs to treat melanoma and corresponding method for treating melanoma.
EFFECT: synergistic effect of the compound combinations in reducing the tumour volume.
4 cl, 9 dwg, 2 tbl, 6 ex
| Title |
Year |
Author |
Number |
| USE OF 2-CARBOXAMIDE-CYCLOAMINO UREA DERIVATIVES IN TREATMENT OF EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENTS TARGETED AT EGFR-FAMILY MEMBERS |
2011 |
- Brakhmann, Zaskia Mariya
- Fritch, Kristin
- Mera, Saver-Mishel
- Shnell, Kristian Rene
- Garsiya-Echeverriya, Karlos
|
RU2589695C2 |
| COMBINATION OF PIK3 INHIBITOR AND INHIBITOR C-MET |
2013 |
- Kaponigro Dzhordano
- Khuan Sichzhun
- Lekhar Dzhozef
- Van Khoj-Tsin
|
RU2705095C2 |
| APPLICATION OF IMIDAZOQUINOLINES FOR TREATMENT OF EGFR-DEPENDENT DISEASES OR DISEASES WITH AQUIRED RESISTANCE TO AGENTS BINDING MEMBERS OF EGFR FAMILY |
2008 |
- Garsija-Ehcheverrija Karlos
- Maira Sove-Mishel'
|
RU2481838C2 |
| PHARMACEUTICAL COMBINATION COMPRISING INHIBITOR PHOSPHATYLENOSITOL 3-KINASES AND AROMATASE INHIBITOR |
2013 |
- Goldbrunner Mikhael
- Khuan Sichzhun
|
RU2651023C2 |
| COMBINATION OF (A) PHOSPHOINOSITIDE-3-KINASE INHIBITOR AND (B) Ras/Raf/Mek PATHAWAY MODULATOR |
2009 |
- Garsija-Ehcheverrija Karlos
- Mera Sove-Mishel'
- St'Juart Darrin
- Vi S'Jusan
- Frich Kristine
- Nejdzhel Tobi
|
RU2508110C2 |
| USING PYRIMIDINE DERIVATIVES FOR TREATING EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENTS AGAINST EGFR FAMILY |
2009 |
- Garsia-Ehcheverria Karlos
- Maira Sove-Mishel'
|
RU2496500C2 |
| COMBINED THERAPY |
2015 |
- Hao, Huaixiang
- Huang, Xizhong
- Tam, Angela
- Kasibhatla, Shailaja
|
RU2695230C2 |
| COMBINATIONS CONTAINING TRANSDUCTION SIGNAL INHIBITOR AND EPOTILONE DERIVATIVE |
2002 |
- Brandt Ral'F
- Bukhdunger Ehlizabet
- Khel'Din Karl-Khenrik
- Estman Arne
- Pitras Kristian
- O`Rejli Terens
- Rotermel Dzhon Dejvid
- Traksler Peter
- Vartmann Markus
|
RU2313345C2 |
| PHARMACEUTICAL COMBINATIONS CONTAINING PYRIDO[4,3-d]PYRIMIDINE DERIVATIVES AS HSP90 INHIBITOR AND HER2 INHIBITOR |
2009 |
- Karlos Garsija-Ehcheverrija
- Mikaehl' Jensen
|
RU2532375C2 |
| COMBINATION CONTAINING IRON COMPLEX AND ANTINEOPLASTIC AGENT, AND USE THEREOF |
2007 |
|
RU2469721C2 |
